Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Shale

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nature Genetics|May 10, 2023
Genetic immune escape landscape in primary and metastatic cancerFrancisco Martínez-Jiménez, Peter Priestley, Charles Shale, et al.
Cell Genomics|February 13, 2023
Unscrambling cancer genomes via integrated analysis of structural variation and copy numberCharles Shale, Daniel L Cameron, Jonathan Baber, et al.
Scientific Reports|June 17, 2022
Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancerJudith M Vlaar, Anouska Borgman, Eric Kalkhoven, et al.
Genome Biology|July 13, 2021
GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasingDaniel L Cameron, Jonathan Baber, Charles Shale, et al.
Nature|October 25, 2019
Pan-cancer whole-genome analyses of metastatic solid tumoursPeter Priestley, Jonathan Baber, Martijn P Lolkema, et al.
Nature Communications|May 20, 2025
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primaryRichard J Rebello, Atara Posner, Ruining Dong, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nature Genetics|May 10, 2023
Genetic immune escape landscape in primary and metastatic cancerFrancisco Martínez-Jiménez, Peter Priestley, Charles Shale, et al.
Cell Genomics|February 13, 2023
Unscrambling cancer genomes via integrated analysis of structural variation and copy numberCharles Shale, Daniel L Cameron, Jonathan Baber, et al.
Scientific Reports|June 17, 2022
Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancerJudith M Vlaar, Anouska Borgman, Eric Kalkhoven, et al.
Genome Biology|July 13, 2021
GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasingDaniel L Cameron, Jonathan Baber, Charles Shale, et al.
Nature|October 25, 2019
Pan-cancer whole-genome analyses of metastatic solid tumoursPeter Priestley, Jonathan Baber, Martijn P Lolkema, et al.
Nature Communications|May 20, 2025
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primaryRichard J Rebello, Atara Posner, Ruining Dong, et al.
Pageof 1